The vascular origin of these tumors was confirmed by immunohistochemical staining of tumors for vascular markers, confirmation of rare endothelial cells in the skin targeted by the GFAP-CreER driver line and recapitulation of the angiosarcoma phenotype using a more specific vascular endothelial driver, Tie2-CreER. The gene discussed is TEK; the disease is angiosarcoma.